Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms

  • Authors:
    • Yan Li
    • Jiying Wang
    • Xiaoyan Li
    • Yujiao Jia
    • Lei Huai
    • Kan He
    • Pei Yu
    • Min Wang
    • Haiyan Xing
    • Qing Rao
    • Zhen Tian
    • Kejing Tang
    • Jianxiang Wang
    • Yingchang Mi
  • View Affiliations

  • Published online on: October 6, 2014     https://doi.org/10.3892/or.2014.3529
  • Pages: 2680-2686
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The Wilms' tumor 1 (WT1) gene is one of the regulating factors in cell proliferation and development. It is a double-functional gene: an oncogene and a tumor suppressor. This gene was found to be highly expressed in many leukemic cell lines and in patients with acute myeloid leukemia. In the present study, we demonstrated that the WT1 gene was commonly expressed in leukemic cell lines apart from U937 cells. The K562 cell line which expresses WT1 at a high level (mRNA and protein) was used in the entire experiment. By MTT and colony formation assays, we found that curcumin, an inhibitor of the WT1 protein, inhibited cell proliferation and clonogenicity in a time- and dose-dependent manner. It also caused cell cycle arrest at the G2/M phase. We then designed specific short hairpin RNAs (shRNAs) which could downregulate WT1 by 70-80% at the mRNA and protein levels. Reduction in the WT1 levels attenuated the proliferative ability and clonogenicity. Cell cycle progression analysis indicated that the proportion of cells in the G0/G1 phase increased while the proportion in the S phase decreased distinctively. ChIP-DNA selection and ligation (DSL) experiment identified a cohort of genes whose promoters are targeted by WT1. These genes were classified into different cellular signaling pathways using MAS software and included the Wnt/β-catenin pathway, MAPK signaling pathway, apoptosis pathway, and the cell cycle. We focused on the Wnt/β-catenin signaling pathway, and compared expression of several genes in the K562 cells transfected with the control shRNA and WT1-specific shRNA. β-catenin, an important gene in the Wnt canonical pathway, was downregulated after WT1 RNAi. Target genes of β-catenin which participate in cell proliferation and cell cycle regulation, such as CCND1 and MYC, were also significantly downregulated. Collectively, these data suggest that WT1 functions as an oncogene in leukemia cells, and one important mechanism is regulation of the Wnt/β-catenin pathway.
View Figures
View References

Related Articles

Journal Cover

December-2014
Volume 32 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Wang J, Li X, Jia Y, Huai L, He K, Yu P, Wang M, Xing H, Rao Q, Rao Q, et al: Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms. Oncol Rep 32: 2680-2686, 2014
APA
Li, Y., Wang, J., Li, X., Jia, Y., Huai, L., He, K. ... Mi, Y. (2014). Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms. Oncology Reports, 32, 2680-2686. https://doi.org/10.3892/or.2014.3529
MLA
Li, Y., Wang, J., Li, X., Jia, Y., Huai, L., He, K., Yu, P., Wang, M., Xing, H., Rao, Q., Tian, Z., Tang, K., Wang, J., Mi, Y."Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms". Oncology Reports 32.6 (2014): 2680-2686.
Chicago
Li, Y., Wang, J., Li, X., Jia, Y., Huai, L., He, K., Yu, P., Wang, M., Xing, H., Rao, Q., Tian, Z., Tang, K., Wang, J., Mi, Y."Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms". Oncology Reports 32, no. 6 (2014): 2680-2686. https://doi.org/10.3892/or.2014.3529